.After F2G's first attempt to acquire a brand-new lesson of antifungal to market was wrecked by the ...
.Moderna has promised to reduce R&D investing through $1.1 billion by 2027. The choice to shrink ...
.Simply 4 months after Sanofi wager $80 million in upfront cash on Fulcrum Therapeutics' losmapimod,...
.Cancer cells provider Oncternal Therapies is folding all its clinical tests and giving up personnel...
.Roche is holding out chances that its injectable obesity prospect could inevitably show 25% weight ...
.Novo Nordisk has lifted the cover on a phase 1 trial of its dental amylin and GLP-1 receptor co-ago...
.Merely a handful of quick full weeks after succeeding an FDA Fast Track tag for its own investigati...
.Not long after a positive information drop for Eli Lilly's efsitora alfa, the Indianapolis-based fi...
.BridgeBio Pharma is actually slashing its genetics treatment budget and also drawing back from the ...
.GSK's attempt to develop the first injection for genital herpes simplex virus (HSV) has ended in br...